Name: Latest research reports of Thyrocare Technologies Ltd. authored by ICICI Securities Limited and published by - Trendlyne research reports.
Item: Thyrocare Technologies Ltd.
Rating: 5
Author: ICICI Securities Limited

Thyrocare Technologies Ltd.

NSE: THYROCARE | BSE: 539871 | ISIN: INE594H01019 | Industry: Healthcare Services
| Expensive Performer

708.6000 2.40 (0.34%)

NSE Apr 17, 2025 15:31 PM

32.83% Fall from 52W High

Volume: 34,017

Thyrocare Technologies Ltd.

24 Jul 2024

708.60

0.34%

Margin thesis is starting to unfold

Buy: Thyrocare Technologies Ltd.

Target

ICICI Securities Limited

Thyrocare Technologies (Thyrocare) has reported a strong 16.4% YoY growth in pathology segment in Q1FY25 in otherwise a seasonally weak quarter.

Thyrocare Technologi.. has an average target of 825.00 from 1 broker.